Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Concerns rise over proposal by CMS to level E/M payments

CMS proposed rule, CMS-1693-P

Key clinical point: Some specialties would be paid less under proposed payment changes for 2019.

Major finding: New patient visits (levels 2-5) would be paid at $135 and established patient visits (levels 2-5) would be paid at $93.

Study details: The physician fee schedule proposal would pay level 2-5 E/M visits at the same rate, and reduce some documentation requirements.

Disclosures: No relevant financial disclosures were reported.

Read the article.

Citation:

CMS proposed rule, CMS-1693-P

This Week's Must Reads

Inadequate emergency care a challenge for rural pediatric patients, Walling EB et al. J Oncol Pract. 2019 Jan 31. doi: 10.1200/JOP.18.00115.

QC measures improve with CMS Oncology Care Model, Rocque G et al. J Oncol Pract. 2019. doi: 10. 1200/JOP.18.00390.

Women less likely to receive industry funds, Weng JK et al. JAMA Netw Open. 2019 Jan. 25. doi: 10.1001/jamanetworkopen.2018.7377.

A shift in Medicare drug coverage may boost costs for patients, Hwang TJ et al. JAMA Int Med. 2019. doi: 10.1001/jamainternmed.2018.6417.

President Trump requests $500 million for pediatric cancer, Trump D. State of the Union Address, Feb. 5, 2019.

Must Reads in Business of Medicine

For lymphoma patients, insurance is a matter of life or death , Goldstein JS et al. Blood. 2018 Jul 24. doi: 10.1182/blood-2018-03-839035

Expansion in clinical trial eligibility requested by ASCO, Friends of Cancer and ASCO letter to the FDA

CMS wants to flatten E/M payments, CMS proposed rule, CMS-1693-P

Lay health workers can assist with end-of-life care, Patel MI et al. JAMA Oncology. 2018 Jul 26. doi: 10.1001/jamaoncol.2018.2446.